Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MNV-201 for the Treatment of Pearson Syndrome
NCT06017869Phase 2Recruiting
- Sponsor
- Minovia Therapeutics
- Start
- Jul 2023
- Primary completion
- Dec 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of MNV-BM-PLC in Pearson syndrome, sponsored by Minovia Therapeutics. Started Jul 2023; status: recruiting.
02
Drugs
MNV-BM-PLC
03
Conditions
Pearson syndrome
Beyond the preview
Go deeper on NCT06017869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06017869.